Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Sep;81(1):159-66.
doi: 10.1038/sj.bjc.6690666.

Trends in cancer of the cervix uteri in Sweden following cytological screening

Affiliations
Free PMC article

Trends in cancer of the cervix uteri in Sweden following cytological screening

R Bergström et al. Br J Cancer. 1999 Sep.
Free PMC article

Abstract

Trends in cervical cancer incidence following the introduction of screening have mostly been studied using cross-sectional data and not analysed separately for squamous cell cancer and adenocarcinomas. Using Swedish nationwide data on incidence and mortality, we analysed trends during more than 3 decades and fitted Poisson-based age-period-cohort models, and also investigated whether screening has reduced the incidence of adenocarcinomas of the cervix. The incidence of reported cancer in situ increased rapidly during 1958-1967. Incidence rates of squamous cell cancer, fairly stable before 1968, decreased thereafter by 4-6% yearly in women aged 40-64, with a much smaller magnitude in younger and older women. An age-cohort model indicated a stable 70-75% reduction in incidence for women born 1940 and later compared with those born around 1923. The incidence of adenocarcinomas doubled during the 35-year study period. The mortality rate increased by 3.6% before 1968 and decreased by 4.0% yearly thereafter. Although a combination of organized and opportunistic screening can reduce the incidence of squamous cell cancer substantially, the incidence of adenocarcinomas appears uninfluenced by screening.

PubMed Disclaimer

References

    1. BMJ. 1999 May 8;318(7193):1244-5 - PubMed
    1. BMJ. 1999 Apr 3;318(7188):904-8 - PubMed
    1. Epidemiol Rev. 1993;15(2):486-98 - PubMed
    1. BMJ. 1994 May 28;308(6941):1407-11 - PubMed
    1. J Natl Cancer Inst. 1995 Feb 1;87(3):175-82 - PubMed

MeSH terms